NEW YORK, Oct. 28, 2011 /PRNewswire/ -- A consortium comprised of investment funds advised by Apax Partners ("Apax"), together with controlled affiliates of Canada Pension Plan Investment Board ("CPPIB") and the Public Sector Pension Investment Board ("PSP Investments"), today announced that shareholders of Kinetic Concepts, Inc. (NYSE: KCI) have approved the consortium's acquisition of KCI for $68.50 per common share in cash, or a total value of approximately $6.3 billion, including KCI's outstanding debt. It is expected that the acquisition will close in early November.
KCI is a U.S.-based medical device company focused on the design, manufacture, marketing and service of therapies and products for the wound care, tissue regeneration and therapeutic support system markets.
In 2010, KCI reported revenues of $2.0 billion. The company's products address a broad range of patient needs and are used by healthcare professionals around the world in a wide range of diverse care settings, such as acute care hospitals, long-term care and skilled nursing facilities, home health agencies and wound care clinics.
The consortium plans to work actively in partnership with the management of KCI to help expand the company's core businesses, invest in innovative new products and extend into new geographies where significant opportunities exist.Buddy Gumina, Partner and co-head of the Apax Healthcare team, commented: "We are pleased to achieve this important milestone and look forward to closing the acquisition. KCI is an excellent business and we believe it has great potential for further growth. We look forward to working with management and our co-sponsors to drive the business forward." Andre Bourbonnais, Senior Vice-President, Private Investments for CPPIB, said, "The outcome of today's vote is a significant step towards the closing of this transaction. Together with KCI's management, Apax and PSP Investments, we look forward to building upon KCI's leading market shares and positioning the company for continued growth and long-term success." Derek Murphy, First Vice President, Private Equity at PSP Investments, said: "We see a number of opportunities to grow the business and look forward to building on the company's outstanding reputation with our partners and the management and employees of KCI. We are proud to be associated with such an innovative company that has truly improved the lives of patients around the world." Morgan Stanley & Co. LLC acted as financial advisor to the consortium. Debt financing was secured from Morgan Stanley & Co. LLC, BofA Merrill Lynch and Credit Suisse AG. Simpson Thacher & Bartlett LLP acted as legal advisor to the consortium. Kirkland & Ellis LLP acted as legal advisor on the financing to the consortium. Epstein Becker Green acted as healthcare regulatory counsel to the consortium. CPPIB was also separately advised by Torys LLP. PSP Investments was also separately advised by Weil, Gotshal & Manges LLP.